Skip to content
Lineage Cell Therapeutics In icon

Lineage Cell Therapeutics In

LCTXStocksBiotechnologyUnited StatesNYSEUSD

Price

$0.93

Today

+2.9%

YTD

-43.6%

Price chart
Closing price history for LCTX (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.

Open positions

0

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-5.05
P/S (TTM)18.59
P/B (TTM)3.86
Market cap$235.28M
Cap tierMicro-cap
Industry avg P/E-2.03

Profitability

Gross margin93.81%
EBIT margin-205.23%
Net margin138.63%
ROE-59.03%
ROA-32.75%

Earnings & Revenue

Revenue (TTM)$13.08M
Revenue growth (1Y)+19.9%
EPS (TTM)-$0.18
Free cash flow$-24.39M
Total debt$2.30M

Dividends & Risk

Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.19
Employees77
Next earnings5 Nov '26
Trade history

Closed trades

0

Realized return

+0.0%

No stored closed trades exist for this instrument yet.

Lineage Cell Therapeutics In (LCTX) | Dirk Kuyken